News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, September 24, 2018

AAMC - FOCI Community,

You have likely been following discussions at your institution and in the national press about disclosure

and transparency issues in light of the recent resignation of Memorial Sloan Kettering Cancer Center’s

Chief Medical Officer, Dr. José Baselga, following a New York Times article about his failure to

disclose industry ties in a large number of publications. The attached memorandum discusses some

of the background, related AAMC activities, and some immediate steps you can take to communicate

with your faculty about this situation and our shared obligation to facilitate the disclosure of timely,

accurate, and complete information about academic medicine’s relationships with industry.

This is the beginning of a much larger conversation in which all of you are engaged at your institutions

and with the AAMC, and we are grateful for the work of this group. With the assistance of the FOCI

Steering Committee leadership and the collaboration of partners across the AAMC membership and

broader research community, we will ensure that you are kept informed about new developments and

involved in these critical issues. Ross McKinney, Chief Scientific Officer, and I are always available to

you for questions or comments, so do not hesitate to reach out to us or to others in this group.

Heather H. Pierce, JD, MPH

Senior Director, Science Policy

Regulatory Counsel, Scientific Affairs

Association of American Medical Colleges

655 K Street NW, Suite 100

Washington, DC 20001

T: 202-478-9926  E: hpierce@aamc.org      website: www.aamc.org

 

 

The Center for Indigenous Health Research and Action (CIHRA) and the OU-Tulsa

Office of Research and Scholarly Development present the 2ND ANNUAL OU-TULSA

COMMUNITY RESEARCH SYMPOSIUM "Trauma-Informed Community Building for Health"

This symposium focuses on the relationship between trauma, health and well-being. Both local and

national presenters will be featured including Julie Miller-Cribbs, PhD, Director & Oklahoma Medicaid

Endowed Professor in Mental Health at the University of Oklahoma Anne & Henry Zarrow School of

Social Work, Emma Elliot-Groves, PhD, Assistant Professor of Medicine, Washington State University,

Schelli Slaughter, DrPH, Director of Public Health, Thurston County Washington, and others.

Presenters will discuss how communities can build hope-informed systems to improve health.

The symposium is free, open to the public, and provides breakfast and lunch. Continuing Education

credits available.

WHERE & WHEN:

Monday, Oct. 22, 2018  8am – 4pm

Schusterman Learning Center  //  Perkins Auditorium // OU-Tulsa

RSVP: https://calendar.ou.edu/tulsa-research/view/event/event_id/69118

For additional information email: ordsa@ouhsc.edu or danielle-fousel@ouhsc.edu

For CIHRA-sponsored events or information email: Charlotte-V-Love@ouhsc.edu

 

 

VPR Staff Editor

Kathy Kyler is the staff editor for the OUHSC campus. Her assistance is available on request without

charge through the office of the Vice President for Research. You can contact her by e-mail at

Kathy-Kyler@ouhsc.edu or by calling ORA at 271-2090. Please allow sufficient time for review.

In general, turnaround time is 7 business days for manuscripts and 5 business days for grant

proposals of 12 pages or less for the research plan.

 

 

NSF SEEKS HIGHER ED INPUT

The National Science Foundation (NSF) announces the launch of the NSF 2026 Idea Machine,

a prize competition to help set the U.S. agenda for fundamental research in science, technology,

engineering, and mathematics (STEM) and STEM education. Participants can earn cash prizes

and receive public recognition by suggesting the pressing research questions that need to be

answered in the coming decade, the next set of “Big Ideas” for future investment by NSF. It's an

opportunity for researchers, the public and other interested stakeholders to contribute to NSF's

mission to support basic research and enable new discoveries that drive the U.S. economy,

enhance national security and advance knowledge to sustain the country's global leadership in

science and engineering.

Entries will be accepted through October 26, 2018. For more information, including entry

instructions, eligibility, rules, and judging criteria, please visit the

https://www.nsf.gov/news/special_reports/nsf2026ideamachine/index.jsp

 

 

The Office of Technology Development will offer the Innovation to Impact Series

Session 2 “Align Your Research With Industry.” You will explore: How to gather useful insights

from the market, Common customer discovery mistakes, and Funding to support market discovery.

This session will occur on September 26th  from Noon- 1:00 pm in Biomedical Research Center

Building,  Room 103. Lunch will be provided.  Space is limited to the first 15 attendees.

 

  

Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS

The abstract submission deadline for the HHDC 2018 Research Symposium is Friday, October 5th

Abstracts must be received by 5 p.m. HHDC 2018 Research Symposium will be held on Friday,

November 16, 2018 at the Samis Education Center in Children’s Hospital in Oklahoma City. The

Symposium will consist of selected oral presentations, a poster session, and Symposia talks by Silvia

Corvera, MD, Professor, University of Massachusetts Medical School, Timothy McGraw PhD,

Professor, Cornell Weill College of Medicine and Morris White, PhD, Professor, Harvard University. 

For abstract submission guidelines and to RSVP for this free event, please go to: 

http://www.haroldhamm.org/Research/Symposium.aspx  Please contact Katie-Hoefling@ouhsc.edu 

with any questions for this event.

 

 

Funding to complete the Master of Science degree in Clinical and Translational Sciences

Now seeking applications for the NIMHD-funded research training and career development program. 

The goal of the program is to facilitate the education of participants from diverse backgrounds under-

represented in biomedical research to pursue clinical research or population health research on diseases

that disproportionately impact minority and rural populations in Oklahoma. 

The program provides two years of partial salary and research support to complete the Master of Science

degree in Clinical and Translational Sciences (MS in CTS) that is administered through the OUHSC

Graduate College.  To be eligible, applicants must hold a clinical doctoral degree or PhD, be from a group

underrepresented in biomedical research (racial and ethnic groups that have been shown by the National

Science Foundation to be underrepresented in biomedical research or individuals with disabilities), be

within seven years of their first faculty appointment, AND plan to pursue a research career focused on

minority health or health disparities research.  The 2-year program covers 50% protected time (salary+fringe),

tuition and fees for the MS in CTS degree program, travel to professional meetings, and modest research funds.

Applications are due 10/15/18.   Application materials can be found at: 

http://osctr.ouhsc.edu/clinical-research-education-and-career-development

For additional information, please contact Julie Stoner, PhD (julie-stoner@ouhsc.edu).

 

 

END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer Conference

Dates: December 6-7, 2018

Location: Samis Education Center

Registration and Call for Abstracts: http://end2cancer.com/

Summary: The END2CANCER conference will start the morning of December 6th, 2018 and conclude

in the afternoon of December 7th, 2018. The conference will bridge laboratory research conducted in

the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis,

imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by

eminent scientists who will discuss new and emerging concepts, technologies and challenges in

translating nanomedicine from bench-to-bedside.

Topics to be discussed in the planned thematic sessions include barriers in drug delivery, discovery

and applications, biological and non-biological systems as carriers and therapeutics, molecular imaging,

biomimetics, immune-oncology, toxicology and clinical trials.

The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers,

physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business

professionals, educators and technology transfer specialists. Students and fellows will have an opportunity

to present their work as a poster presentation and compete for awards.

 

 

NIH NOTICES

Notice of Participation of ECHO in RFA-ES-18-011 "Human Health Exposure Analysis Resource:

Targeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)" (NOT-OD-18-223)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-223.html

 

Notice of Participation of ECHO in RFA-ES-18-012 "Human Health Exposure Analysis Resource:

Untargeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)" (NOT-OD-18-224)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-224.html

 

Notice of Participation of ECHO in RFA-ES-18-013 "Human Health Exposure Analysis Resource:

Environmental Monitoring Laboratories (U2C Clinical Trial Not Allowed)" (NOT-OD-18-225)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-225.html

 

NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria

for Fellowship Award Applications (NOT-OD-18-227)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-227.html

 

NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria

for Research Grant Applications (NOT-OD-18-228)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-228.html

 

NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria

for Career Development Award Applications (NOT-OD-18-229)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-229.html

 

Reminder: NIH Natural Disaster Policy - Hurricane Florence (NOT-OD-18-231)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-231.html

 

Notice of Early Expiration of PAR-17-048 "Phylodynamic Tracking of HIV Transmission (R01)"

(NOT-AI-18-058)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-18-058.html

 

Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin

Diseases (NIAMS) Strategic Plan for Fiscal Years (FY) 2020-2024 (NOT-AR-19-009)

https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-009.html

 

Notice of Change to Key Dates in PAR-18-249 "Quantitative Imaging Tools and Methods for Cancer

Response Assessment (U01 Clinical Trial Optional)" (NOT-CA-18-093)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-093.html

 

Notice of Change to the Eligibility of Foreign Components in PA-18-060, " Neuroscience Research

on Drug Abuse (R01)" (NOT-DA-18-042)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-042.html

 

Notice of Change to the Eligibility of Foreign Components in PA-18-078, " Neuroscience Research

on Drug Abuse (R21)" (NOT-DA-18-043)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-043.html

 

Development of New Antibacterial Drugs Active Against Multi-Drug Resistant Bacteria (NOT-FD-18-016)
https://grants.nih.gov/grants/guide/notice-files/NOT-FD-18-016.html

 

Notice of NICHD's Participation in PA-18-817 "Administrative Supplements for Research on Dietary

Supplements (Admin Supp - Clinical Trial Not Allowed)" (NOT-HD-18-016)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-016.html

 

Notice of Change in Expiration Date for PAR-18-853 "Drug Transport Across the Blood-Testis and

Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)" (NOT-HD-18-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-019.html

 

Notice of Pre-Application Technical Assistance Webinar for RFA-MD-18-011, Limited Competition:

RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed) (NOT-MD-18-016)
https://grants.nih.gov/grants/guide/notice-files/NOT-MD-18-016.html

 

Notice of Intent to Publish a Funding Opportunity Announcement to Support Institutional Translational

Research Training Programs (T32) (NOT-NS-18-077)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-077.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Exploratory Grant for

Morris K. Udall Center without Walls for Parkinsons Disease Research (P20) (NOT-NS-18-083)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-083.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Morris K. Udall Centers

of Excellence for Parkinsons Disease Research (P50) (NOT-NS-18-084)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-083.html

 

Notice of Intent to Publish a Funding Opportunity Announcement to Support NINDS-Specific

Institutional Research Training Programs (T32) (NOT-NS-18-085)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-085.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Post-Stroke VCID in the United

States Including in Health Disparities Populations (U19 Clinical Trial Not Allowed) (NOT-NS-18-092)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-092.html

 

Notice of Correction to Application Forms Package for PA-17-326 "Administrative Supplements for

the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supplement)"

(NOT-NS-18-093)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-093.html

 

Notice of Change to Receipt Date on Pre-application for the NIH-Industry Program: Discovering New

Therapeutic Uses for Existing Molecules (X02 Clinical Trial Not Allowed) (PAR-18-909) (NOT-TR-18-032)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-18-032.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing

Career Development toward Improved Care of Older Adults across Specialties and Disciplines

(U24 - Clinical Trial Optional) (RFA-AG-19-024) – Deadline February 4, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-024.html

 

Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)

(RFA-CA-18-029) – Deadline November 15, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-029.html

 

Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating

Center (DMACC) (U24 Clinical Trials Required) (RFA-CA-18-030) – Deadline November 15, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-030.html

 

Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical

Trial Optional) (RFA-CA-19-001) – Deadline January 9, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-001.html

 

Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)

(RFA-CA-19-016) – Deadline December 7, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-016.html

 

Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial

Optional) (RFA-DK-18-017) – Deadline February 21, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-017.html

 

Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research

Network (LURN) Research Sites (U01 Clinical Trial Not Allowed) (RFA-DK-18-510)

Deadline November 14, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-510.html

 

Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research

Network (LURN) Data Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-DK-18-511)

Deadline November 14, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-511.html

 

Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic

Pain (MAPP) Research Network Discovery Sites (U01 Clinical Trial Not Allowed) (RFA-DK-18-513)

Deadline November 14, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-513.html

 

Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic

Pelvic Pain (MAPP) Research Network Data Coordinating Core (DCC) (U24 Clinical Trial Not Allowed)

(RFA-DK-18-514) Deadline November 14, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-514.html

 

Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic

Pelvic Pain (MAPP) Research Network Tissue and Technology Core (TATC) (U24 Clinical Trial Not Allowed)

(RFA-DK-18-515) – Deadline November 14, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-515.html

 

Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation

of PCOR Evidence (R18) (RFA-HS-18-002) – Deadline January 4, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-HS-18-002.html

 

NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education

Experiences (R25) (RFA-NS-19-007) – Deadline February 15, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-007.html

 

AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) (PA-18-916)

Deadline February 16, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-18-916.html

 

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 –

Clinical Trial Optional) (PA-18-917) – Deadline February 5, 2019 
https://grants.nih.gov/grants/guide/pa-files/PA-18-917.html

 

NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research

Career Development (Admin Supp Clinical Trial Optional) (PA-18-920) – Deadline December 1, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-920.html

 

Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) (PAR-18-918)

Deadline February 16, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-918.html

 

Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)

(PAR-18-919) – Deadline February 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-919.html

 

HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) (PAS-18-915)

Deadline January 7, 2019
https://grants.nih.gov/grants/guide/pa-files/PAS-18-915.html

 

 

New Clinical Study Opportunities

***************************************************************

Please note this is NOT a solicitation for study subjects

***************************************************************

Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:

  • VEGFR Inhibitor- induced Hand Foot Skin Reaction #117716
  • Tumor Sampling/Genome Sequencing
  • Systemic Lupus Erythematosus Study D3465C00001
  • Phase III Program treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with

Primary Autonomic Failure

  • Atopic Dermatitis
  • Single Cohort Phase 4 Trial Investigating the Impact of G-CSF Primary Prophylaxis for Advanced

Stage Hodgkin’s Lymphoma Patients Treated with A+AVD

  • eSIF Study
  • Parenteral Nutrition In Hospitalized Neonates, Preterm Infants And Pediatric Patients #118601_24

Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on any of

these studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the Office

of Research Administration.

Print

x